{"SPADE_UN_16307": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_16307", "Peptide Name": "AmphiArc2 Off2.2.3", "Source": "Synthetic", "Family": "", "Gene": "Not found", "Sequence": "HLLKKWRTWLRKAWHIVGKV", "Sequence Length": 20, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Tumor cells:MCF-7 (EC50=7 ± 1 µM); A549 (EC50=9 ± 1 µM)", "Hemolytic Activity": "Human erythrocytes:HC50=59 ± 6 µM", "Cytotoxicity": "HDMEC:EC50=6.1 ± 0.5 µM", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Free", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C124H195N37O22", "Mass": 2556.11, "PI": 12.0, "Net Charge": 8, "Hydrophobicity": -0.43, "Half Life": "Mammalian:3.5 hourYeast:10 minE.coli:>10 hour", "Literature": [{"Title": "In silico design and optimization of selective membranolytic anticancer peptides", "Pubmed ID": "31375699", "Reference": "Sci Rep. 2019 Aug 2;9(1)11282.", "Author": "Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=31375699"}], "Frequent Amino Acids": "KLW", "Absent Amino Acids": "CDEFMNOPQSUY", "Basic Residues": 8, "Acidic Residues": 0, "Hydrophobic Residues": 10, "Polar Residues": 12, "Positive Residues": 8, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_27598", "Similarity": 1.0, "Sequence": "LNWGALLKHLLK"}, {"SPADE_ID": "SPADE_UN_28200", "Similarity": 1.0, "Sequence": "VGKVLKQLKKVSAVAKVAMKKGAALLK"}, {"SPADE_ID": "SPADE_UN_00418", "Similarity": 0.8333333333333334, "Sequence": "KWFKKIPKFLHLLKKF"}]}}}